NP
GH icon

Ninepoint Partners’s Guardant Health GH Stock Holding History

Ninepoint Partners’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.85M Buy
19,018
+6,024
+46% +$655K 0.22% 53
2026
Q1 		$1.2M Buy
+12,994
New +$1.3M 0.09% 87

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Ninepoint Partners's GH Position: Q2 2026 in Review

Ninepoint Partners increased its Guardant Health (GH) stake by 46% in Q2 2026, buying an estimated $655K and bringing the position to 19,018 shares worth $2.85M. The position accounts for 0.22% of the portfolio, ranked #53.

Ninepoint Partners first reported a position in GH in Q1 2026 and has held it in 2 quarters since. 422 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Ninepoint Partners held 19,018 shares of Guardant Health worth $2.85M as of Q2 2026.
  • Ninepoint Partners bought 6,024 Guardant Health shares in Q2 2026, an estimated $655K.
  • Guardant Health made up 0.22% of Ninepoint Partners's portfolio in Q2 2026, its #53 holding.
  • Ninepoint Partners first reported a position in Guardant Health in Q1 2026 and has held it in 2 quarters since.
  • 422 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Ninepoint Partners's 13F filing for Q2 2026, filed 11 Aug 2026.